Dr Reddys Laboratories Says Its Andhra Plant Gets Two Observations From Usfda
The Us Food And Drug Administration (Usfda) Completed A Pre-Approval Inspection At The Company'S Formulations Manufacturing Facility Fto 11 In Srikakulam, Andhra Pradesh On Thursday, Dr Reddy'S Said In A Regulatory Filing. The Inspection Was Conducted From June 30, 2022 To July 7, 2022Dr Reddy'S Laboratories Ltd On Thursday Said The Us Health Regulator Has Issued Form 483 With Two Observations After Inspecting Its Manufacturing Facility Located At Srikakulam In Andhra Pradesh. As Per Usfda, Form 483 Is Issued To A Firm'S Management At The Conclusion Of An Inspection When The Investigator Has Observed Any Conditions That In Its Judgment May Constitute Violations Of The Food Drug And Cosmetic (Fd&C) Act And Related Acts. The Us Food And Drug Administration (Usfda) Completed A Pre-Approval Sirkakulam, Andhra Pradesh On Thursday, Dr Reddy'S Said In A Regulatory Filing. The Inspection Was Conducted From June 30, 2022 To July 7, 2022. "We Have Been Issued A Form 483 With Two Observations, Which We Will Address Within The Stipulated Timeline," The Company Added
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!